BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Express Scripts
Baxter
Dow
Merck
UBS
Cerilliant
Covington
Fuji

Generated: January 22, 2018

DrugPatentWatch Database Preview

Zileuton - Generic Drug Details

« Back to Dashboard

What are the generic sources for zileuton and what is the scope of zileuton freedom to operate?

Zileuton
is the generic ingredient in three branded drugs marketed by Rising Pharms Inc and Chiesi Usa Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for zileuton. Three suppliers are listed for this compound.
Pharmacology for zileuton

US Patents and Regulatory Information for zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-001 Dec 9, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-003 Dec 9, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rising Pharms Inc ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 204929-001 Mar 17, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-003 Dec 9, 1996 ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Subscribe ➤ Subscribe
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-001 Dec 9, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
McKinsey
Fish and Richardson
Medtronic
Accenture
Fuji
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot